Frequently Asked Questions
Liver Cirrhosis Drugs Market to grow at a CAGR of 10.95% by forecast 2029.
North America region holds the largest share in the market.
The countries covered in the liver cirrhosis drugs market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
Major players operating in the liver cirrhosis drugs market are Regeneron Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., GlaxoSmithKline Plc, Mylan N.V, Sanofi S.A, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd, Boehringer Ingelheim International GmbH, Johnson & Johnson Private Limited, Sunovion Pharmaceuticals Inc., Novartis AG, Bayer AG, AstraZeneca, Merck & Co., Inc., Swedish Orphan Biovitrum AB, Aurobindo Pharma, and AbbVie Inc.
